Similar articles

• [Crosstalk between the immune and skeletal system].

  Takayanagi H. Takayanagi H. Ryumachi. 2003 Oct;43(4):624-31. Ryumachi. 2003. PMID: 14598653 Review. Japanese. No abstract available.
• [Gene regulation network in the skeletal system].

  Takayanagi H. Takayanagi H. Tanpakushitsu Kakusan Koso. 2004 Dec;49(17 Suppl):2943-9. Tanpakushitsu Kakusan Koso. 2004. PMID: 15669281 Review. Japanese. No abstract available.
• [Involvement of osteoclasts in cartilage and bone destruction in rheumatoid arthritis].

  Hikita A, Tanaka S. Hikita A, et al. Nihon Rinsho. 2005 Jan;63 Suppl 1:84-6. Nihon Rinsho. 2005. PMID: 15799323 Review. Japanese. No abstract available.
• [Role of osteoclasts in bone destruction in rheumatoid arthritis].

  Suzuki Y. Suzuki Y. Nihon Rinsho Meneki Gakkai Kaishi. 2001 Jun;24(3):87-97. Nihon Rinsho Meneki Gakkai Kaishi. 2001. PMID: 16578961 Review. Japanese. No abstract available.
• The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.

  Urushibara M, Takayanagi H, Koga T, Kim S, Isobe M, Morishita Y, Nakagawa T, Löeffler M, Kodama T, Kurosawa H, Taniguchi T. Urushibara M, et al. Arthritis Rheum. 2004 Mar;50(3):794-804. doi: 10.1002/art.20206. Arthritis Rheum. 2004. PMID: 15022321